The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Combining semiconductor-based sequencing with amplicon-based cancer gene panels: A rapid next-gen approach to clinical cancer genotyping.
Christopher L. Corless
Consultant or Advisory Role - Novartis; Pfizer
Honoraria - Ion Torrent Systems; Novartis
Research Funding - Ion Torrent Systems; Novartis
Tanaya Neff
No relevant relationships to disclose
Michael C. Heinrich
Consultant or Advisory Role - MolecularMD; Novartis
Stock Ownership - MolecularMD
Research Funding - Novartis
Carol Beadling
No relevant relationships to disclose